While federal and state data show a notable decline in opioid-related fatalities nationwide, public health officials and medical professionals warn that overdoses involving illicit stimulants such as methamphetamine and cocaine are rising The Guardian reported in an article published on November 8, 2026. According to provisional Centers for Disease Control and Prevention data, fentanyl-involved overdose deaths dropped to pre-pandemic levels nationally in 2025. However, during the same period, deaths involving cocaine increased in 13 states, while methamphetamine-involved fatalities rose in eight states.
This shift has created complex clinical and emergency response challenges. Public health campaigns have successfully trained the public to recognize opioid overdoses and administer naloxone, a medication that rapidly reverses opioid-induced respiratory depression. By contrast, stimulant overdoses lack a direct pharmacological reversal agent, making bystander intervention significantly more complicated.
The Clinical Challenge of Overstimulation
Dr. Taylor Nichols, an emergency and addiction medicine physician in Sacramento, noted that stimulants have effectively filled the gap left by declining fentanyl overdoses. Unlike opioids, which cause a predictable and clear-cut slowing of breathing, stimulant overdoses involve excessive neurochemical activity that strains the brain and cardiovascular system.
“A stimulant overdose can be as simple as releasing too much stimulation into your brain and into your body,” Nichols explained. The resulting extreme overstimulation can trigger acute medical emergencies such as heart attacks, strokes, and seizures. Medical experts recommend utilizing the BE FAST mnemonic—Balance loss, Eyesight changes, Face droop, Arm weakness, Speech difficulty, and Time to call 911—to identify stroke symptoms when responding to suspected stimulant toxicity.
Regional Trends and State-Level Data
The divergence between declining opioid deaths and rising stimulant fatalities is evident across multiple jurisdictions. In Minnesota, state health officials reported that opioid-involved overdose deaths fell from a peak of 1,039 in 2022 to 671 in 2025, according to data released by the Minnesota Department of Health on October 29, 2026. Despite the reduction in opioid fatalities, Minnesota’s total drug overdose deaths increased by 3 percent—rising from 994 in 2024 to 1,025 in 2025—driven entirely by an increase in stimulant-related deaths and non-fatal hospitalizations.
Dr. Brooke Cunningham, Minnesota’s health commissioner, emphasized that while public health programs have made substantial progress against opioids through a comprehensive approach combining prevention, naloxone distribution, treatment, and harm reduction, authorities must now address the rising public health risks associated with expanded stimulant use.
Bystander Response and Safety Protocols
Because naloxone is ineffective against pure stimulant overdoses, emergency responders and harm reduction advocates emphasize behavioral and environmental management while awaiting professional medical care. Dalton Barrett, a paramedic and opioid settlement fund manager in rural Edgecombe County, North Carolina, recommends reducing external stimuli—such as bright lights, crowds, and loud music—to help patients remain calm.
“What we don’t want to happen is we get over there, and now they’re aggressive with the EMS staff, and now law enforcement’s coming, and the person gets tased or maced or put in handcuffs,” Barrett said, noting that unnecessary physical altercations complicate medical treatment.
Experts also emphasize that when a patient loses consciousness during an overdose event, it is impossible for a bystander to rule out concurrent opioid use. Because administering naloxone carries no adverse medical risk to someone experiencing a pure stimulant overdose, health advocates advise its use whenever opioid involvement remains uncertain.